Breakthrough DRGS Treatment Offers Hope for Chronic Pain Sufferers

A new treatment for chronic regional pain syndrome (CRPS) is showing promising results. Known as dorsal root ganglion stimulation (DRGS), it uses electric pulses to reduce pain by targeting a key nerve centre in the spine. Early studies suggest it may offer significant relief for patients who have struggled with other treatments. CRPS is a condition where nerve cells become overly sensitive, causing extreme pain even from light touch or movement. Unlike normal pain, which acts as a warning, CRPS turns pain into a long-term disease. The disorder stems from structural changes in the dorsal root ganglion (DRG), a cluster of nerves in the spinal cord that filters pain signals for specific body parts.

DRGS works by placing a small device near the DRG to block or slow pain signals. The procedure takes 60 to 90 minutes, during which doctors implant a pulse generator and leads over the affected nerve area. Once active, the device helps reprogram nerve cells, reducing their sensitivity and restoring more normal pain responses. Initial research indicates that 70-80% of CRPS patients treated with DRGS experience at least 80% pain relief. This compares to just 52% of patients who tried spinal cord stimulation, another common treatment. Doctors typically consider DRGS only after other methods—such as medications, nerve blocks, or physical therapy—have failed to provide relief. While effective, the treatment carries some risks, including bleeding, infection, and the need for battery replacement every five to six years. Despite these drawbacks, DRGS has also shown potential in managing other types of chronic pain beyond CRPS.

For many with CRPS, DRGS represents a major step forward in pain management. The treatment’s high success rate in early trials suggests it could become a standard option for those who don’t respond to conventional therapies. With further development, it may also expand to help patients suffering from different chronic pain conditions.